DURHAM, NC -- (MARKET WIRE) -- May 22, 2007 -- Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced the appointment of Dr. Martin J. Murphy, Jr. to its Board of Directors. This addition will bring Aldagen’s Board to 5 members.
